RU2018106948A - METHOD FOR PRODUCING SUBSTITUTED 3- (2-ANILINO-1-CYCLOGEXYL-1H-BENZIMIDAZOL-5-IL) PROPANIC ACID DERIVATIVES - Google Patents
METHOD FOR PRODUCING SUBSTITUTED 3- (2-ANILINO-1-CYCLOGEXYL-1H-BENZIMIDAZOL-5-IL) PROPANIC ACID DERIVATIVES Download PDFInfo
- Publication number
- RU2018106948A RU2018106948A RU2018106948A RU2018106948A RU2018106948A RU 2018106948 A RU2018106948 A RU 2018106948A RU 2018106948 A RU2018106948 A RU 2018106948A RU 2018106948 A RU2018106948 A RU 2018106948A RU 2018106948 A RU2018106948 A RU 2018106948A
- Authority
- RU
- Russia
- Prior art keywords
- amino
- trimethylcyclohexyl
- phenyl
- compound
- propanoic acid
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
- C07D235/30—Nitrogen atoms not forming part of a nitro radical
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Claims (68)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP15178413 | 2015-07-27 | ||
EP15178413.9 | 2015-07-27 | ||
PCT/EP2016/067614 WO2017017046A1 (en) | 2015-07-27 | 2016-07-25 | Method for preparing substituted 3-(2-anilino-1-cyclohexyl-1h-benzimidazol-5-yl)propanoic acid derivatives |
Publications (1)
Publication Number | Publication Date |
---|---|
RU2018106948A true RU2018106948A (en) | 2019-08-27 |
Family
ID=53758091
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RU2018106948A RU2018106948A (en) | 2015-07-27 | 2016-07-25 | METHOD FOR PRODUCING SUBSTITUTED 3- (2-ANILINO-1-CYCLOGEXYL-1H-BENZIMIDAZOL-5-IL) PROPANIC ACID DERIVATIVES |
Country Status (18)
Country | Link |
---|---|
US (1) | US10703727B2 (en) |
EP (1) | EP3328838A1 (en) |
JP (1) | JP6787998B2 (en) |
KR (1) | KR20180030906A (en) |
CN (1) | CN107848985B (en) |
AR (1) | AR105494A1 (en) |
AU (1) | AU2016299329B2 (en) |
BR (1) | BR112018001535A2 (en) |
CA (1) | CA2993480A1 (en) |
CL (1) | CL2018000241A1 (en) |
CO (1) | CO2018000795A2 (en) |
HK (1) | HK1252848A1 (en) |
IL (1) | IL256926A (en) |
MX (1) | MX2018001204A (en) |
PE (1) | PE20181039A1 (en) |
RU (1) | RU2018106948A (en) |
TW (1) | TW201718513A (en) |
WO (1) | WO2017017046A1 (en) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EA031655B1 (en) | 2014-02-11 | 2019-02-28 | Байер Фарма Акциенгезельшафт | BENZIMIDAZOL-2-AMINES AS mIDH1 INHIBITORS |
WO2015121209A1 (en) | 2014-02-11 | 2015-08-20 | Bayer Pharma Aktiengesellschaft | Benzimidazol-2-amines as midh1 inhibitors |
CA2965213A1 (en) | 2014-10-23 | 2016-04-28 | Bayer Pharma Aktiengesellschaft | 1-cyclohexyl-2-phenylaminobenzimidazoles as midh1 inhibitors for the treatment of tumors |
CN107810176B (en) | 2015-06-08 | 2020-10-16 | 德国癌症研究公共权益基金会 | N-menthyl benzimidazoles as mIDH1 inhibitors |
ES2877424T3 (en) | 2015-07-07 | 2021-11-16 | Deutsches Krebsforschungszentrum Stiftung Des Oeffentlichen Rechts | 2-Aryl- and 2-arylalkyl-benzimidazoles as MIDH1 inhibitors |
JP6824954B2 (en) | 2015-07-16 | 2021-02-03 | ドイチェス クレープスフォルシュングスツェントルム シュティフトゥング デス エッフェントリッヒェン レヒツ | 5-Hydroxyalkylbenzimidazole as an mIDH1 inhibitor |
EP3121166A1 (en) | 2015-07-21 | 2017-01-25 | Bayer Pharma Aktiengesellschaft | Fused imidazoles as midh1 inhibitors |
TW201708193A (en) * | 2015-07-27 | 2017-03-01 | 拜耳製藥公司 | Inhibiton of the mutated isocitrate dehydrogenase IDH1 R132H |
JP2020535112A (en) | 2017-08-01 | 2020-12-03 | ドイッチェス・クレープスフォルシュングスツェントルムDeutsches Krebsforschungszentrum | Combination of MIDH1 inhibitor and DNA hypomethylating agent (HMA) |
CA3104760C (en) | 2018-06-26 | 2023-09-26 | Kpc Pharmaceuticals, Inc. | Benzimidazole derivatives and use thereof as idh1 inhibitors |
TWI760017B (en) * | 2019-12-23 | 2022-04-01 | 大陸商昆藥集團股份有限公司 | Salt form, crystalline form of idh1 mutant inhibitor and preparation method thereof |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9125901B2 (en) * | 2009-06-23 | 2015-09-08 | The Translational Genomics Research Institute | 4-(benzimidazol-2-ylamino)benzamide derivatives and salts or solvates thereof |
EA031655B1 (en) | 2014-02-11 | 2019-02-28 | Байер Фарма Акциенгезельшафт | BENZIMIDAZOL-2-AMINES AS mIDH1 INHIBITORS |
WO2015121209A1 (en) | 2014-02-11 | 2015-08-20 | Bayer Pharma Aktiengesellschaft | Benzimidazol-2-amines as midh1 inhibitors |
CA2965213A1 (en) | 2014-10-23 | 2016-04-28 | Bayer Pharma Aktiengesellschaft | 1-cyclohexyl-2-phenylaminobenzimidazoles as midh1 inhibitors for the treatment of tumors |
CN107108522B (en) | 2014-10-23 | 2020-12-01 | 德国癌症研究中心 | Benzimidazol-2-amines as mIDH1 inhibitors |
CN107810176B (en) * | 2015-06-08 | 2020-10-16 | 德国癌症研究公共权益基金会 | N-menthyl benzimidazoles as mIDH1 inhibitors |
ES2877424T3 (en) | 2015-07-07 | 2021-11-16 | Deutsches Krebsforschungszentrum Stiftung Des Oeffentlichen Rechts | 2-Aryl- and 2-arylalkyl-benzimidazoles as MIDH1 inhibitors |
JP6824954B2 (en) | 2015-07-16 | 2021-02-03 | ドイチェス クレープスフォルシュングスツェントルム シュティフトゥング デス エッフェントリッヒェン レヒツ | 5-Hydroxyalkylbenzimidazole as an mIDH1 inhibitor |
EP3121166A1 (en) | 2015-07-21 | 2017-01-25 | Bayer Pharma Aktiengesellschaft | Fused imidazoles as midh1 inhibitors |
TW201708193A (en) | 2015-07-27 | 2017-03-01 | 拜耳製藥公司 | Inhibiton of the mutated isocitrate dehydrogenase IDH1 R132H |
-
2016
- 2016-07-14 TW TW105122263A patent/TW201718513A/en unknown
- 2016-07-25 KR KR1020187005191A patent/KR20180030906A/en unknown
- 2016-07-25 PE PE2018000132A patent/PE20181039A1/en unknown
- 2016-07-25 AU AU2016299329A patent/AU2016299329B2/en not_active Ceased
- 2016-07-25 EP EP16741641.1A patent/EP3328838A1/en not_active Withdrawn
- 2016-07-25 US US15/748,027 patent/US10703727B2/en active Active
- 2016-07-25 MX MX2018001204A patent/MX2018001204A/en unknown
- 2016-07-25 CA CA2993480A patent/CA2993480A1/en not_active Abandoned
- 2016-07-25 BR BR112018001535A patent/BR112018001535A2/en not_active Application Discontinuation
- 2016-07-25 RU RU2018106948A patent/RU2018106948A/en not_active Application Discontinuation
- 2016-07-25 CN CN201680043928.5A patent/CN107848985B/en active Active
- 2016-07-25 WO PCT/EP2016/067614 patent/WO2017017046A1/en active Application Filing
- 2016-07-25 JP JP2018504195A patent/JP6787998B2/en active Active
- 2016-07-27 AR ARP160102275A patent/AR105494A1/en unknown
-
2018
- 2018-01-15 IL IL256926A patent/IL256926A/en unknown
- 2018-01-26 CO CONC2018/0000795A patent/CO2018000795A2/en unknown
- 2018-01-26 CL CL2018000241A patent/CL2018000241A1/en unknown
- 2018-09-21 HK HK18112179.8A patent/HK1252848A1/en unknown
Also Published As
Publication number | Publication date |
---|---|
EP3328838A1 (en) | 2018-06-06 |
KR20180030906A (en) | 2018-03-26 |
CL2018000241A1 (en) | 2018-07-13 |
HK1252848A1 (en) | 2019-06-06 |
PE20181039A1 (en) | 2018-07-03 |
AR105494A1 (en) | 2017-10-11 |
CO2018000795A2 (en) | 2018-05-10 |
CN107848985B (en) | 2021-09-03 |
MX2018001204A (en) | 2018-04-24 |
CA2993480A1 (en) | 2017-02-02 |
US10703727B2 (en) | 2020-07-07 |
AU2016299329A1 (en) | 2018-02-01 |
WO2017017046A1 (en) | 2017-02-02 |
US20180222871A1 (en) | 2018-08-09 |
IL256926A (en) | 2018-03-29 |
BR112018001535A2 (en) | 2018-09-18 |
JP6787998B2 (en) | 2020-11-18 |
AU2016299329B2 (en) | 2020-08-13 |
CN107848985A (en) | 2018-03-27 |
TW201718513A (en) | 2017-06-01 |
JP2018527328A (en) | 2018-09-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
RU2018106948A (en) | METHOD FOR PRODUCING SUBSTITUTED 3- (2-ANILINO-1-CYCLOGEXYL-1H-BENZIMIDAZOL-5-IL) PROPANIC ACID DERIVATIVES | |
JP2011126894A5 (en) | ||
ES2660288T3 (en) | Quinolone derivatives | |
JP2017526727A5 (en) | ||
JP2016515562A5 (en) | ||
RU2015102723A (en) | OBTAINING 2- (5-BROMO-4- (4-CYCLOPROPYLNAFTALIN-1-IL) -4H-1,2,4-TRIAZOL-3-ILTIO) ACETIC ACID | |
UA107174C2 (en) | THE Crystalline Forms of Saxagliptin and the Process of Obtaining It (OPTIONS) | |
JP2016535031A5 (en) | ||
RU2017109814A (en) | CRYSTALLINE 7- {(3S, 4S) -3 - [(CYCLOPROPYLAMINO) METHYL] -4-fluoropyrrolidin-1-yl} -6-fluorine-1- (2-fluoroethyl) -8-methoxy-4-oxo-1, 4-dihydroquinoline-3-carboxylic acid | |
RU2018145948A (en) | CRYSTAL OF PYRROLOPYRIMIDINE FOR OBTAINING JAK-INHIBITOR | |
US20150353577A1 (en) | Method for producing (1s,4s,5s)-4-bromo-6-oxabicyclo[3.2.1]octan-7-one | |
RU2012112050A (en) | DERIVATIVES OF DIHYDROPERTERIDINONE, METHOD FOR PRODUCING THERE AND PHARMACEUTICAL USE | |
JP2019535723A5 (en) | ||
RU2016123144A (en) | A COMPLETE ETHERAL CHIRAL COMPOUND (N-SUBSTITUTED IMIDAZOLE) -CARBOXYLIC ACID CONTAINING A SIMPLE ETHERAL SIDE CHAIN, ITS PRODUCTION AND APPLICATION | |
RU2016104844A (en) | DERIVATIVES OF N-UREA SUBSTITUTED AMINO ACIDS AS MODULAR PEPTIDE RECEPTOR MODULATORS | |
JP2018534338A5 (en) | ||
RU2012128887A (en) | METHOD FOR PRODUCING MOXIFLOXACIN HYDROCHLORIDE AND ITS INTERMEDIATE PRODUCTS | |
RU2018115278A (en) | EGFR KINASE INHIBITOR, METHOD FOR ITS PRODUCTION AND APPLICATION | |
RU2015151359A (en) | SYNTHESIS OF 3- (5-AMINO-2-METHYL-4-OXOCHINAZOLIN-3 (4H) -YL) PIPERIDIN-2, 6-DIONE | |
AR083595A1 (en) | DERIVATIVES OF INDOL AND THE PROCESS FOR PREPARATION | |
RU2017131253A (en) | METHODS FOR PRODUCING FLUOROKETOLIDES | |
JP2008546642A (en) | Substituted tetrafluorobenzylaniline compound and method for producing pharmaceutically acceptable salt thereof | |
AR081267A1 (en) | PROCEDURE FOR OBTAINING THE CRYSTAL FORM A OF FEBUXOSTAT | |
RU2018102590A (en) | Compounds C, O-Spiro-aryl-glycosides, their preparation and their use | |
RU2014114381A (en) | Salts of Heterocyclyl Amide Substituted Imidazoles with Sulfonic Acid |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA93 | Acknowledgement of application withdrawn (no request for examination) |
Effective date: 20190726 |